In addition, lncRNA-CDC6 promotes the progression and metastasis of breast cancer through direct competitive combination of microRNA-215 (miR-215) as competitive endogenous RNA (ceRNA), which provides a new biomarker for clinical prognosis of breast cancer [20]. This evidence concerns the gene CDC6 and breast cancer.